Name
EphB1+EphB2+EphB3+EphB4 Antibody
Catalog number
bs-7045R
Size
0.1ml
Price
263 EUR
Modification(s)
None
Gene ID number
2047
Cross reactivity
Human
French translation
anticorps
Concentration
1ug per 1ul
Conjugation
Unconjugated
Category
Primary Antibodies
Modification site(s)
Unmodified antibody
Clonality
Polyclonal antibody
Clone number
Polyclonal antibody
Tested Applications
WB, IHC-P, IF(IHC-P)
Target Antigen
EphB1+EphB2+EphB3+EphB4
Long name
EphB1+EphB2+EphB3+EphB4 Antibody
Also known as
EphB1+EphB2+EphB3+EphB4 Antibody
Purification method
This antibody was purified via Protein A.
Recommended dilutions
WB(1:100-1000), IHC-P(1:100-500), IF(IHC-P)(1:50-200)
Specificity
This is a highly specific antibody against EphB1+EphB2+EphB3+EphB4.
Cross reactive species details
Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.
Source
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human EphB1+EphB2+EphB3+EphB4
Storage conditions
Keep the antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for up to 1 year.
Properties
If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
Background of the target antigen
Receptor for members of the ephrin-B family. Binds to ephrin-B1, -B2 and -B3. Binding with the guidance cue ephrin-B2 at the optic chiasm midline redirect ventrotemporal (VT) retinal ganglion cells (RGCs) axons ipsilaterally. May be involved in cell-cell interactions in the nervous system.
Synonym names
CAPB;DRT;EK2;EK5;EK6;ELK;elk related tyrosine kinase;EPH like kinase 2;EPH like kinase 6;EPH like tyrosine kinase 2;eph tyrosine kinase 2;eph tyrosine kinase 3;EPH-like kinase 6;Ephb1;EPHB1_HUMAN;EPHB2;EPHB3;EPHB4;ephrin receptor EphB4;ephrin type B receptor 1;ephrin type B receptor 2;ephrin type B receptor 3;ephrin type B receptor 4;Ephrin type-B receptor 1;EPHT2;EPHT3;ERK;ETK2;Hek 5;Hek 6;HEK2;HEK5;HEK6;hepatoma transmembrane kinase;HTK;human embryo kinase 2;MYK1;NET;PCBC;protein tyrosine kinase HEK5;renal carcinoma antigen NY REN 47;soluble EPHB1 variant 1;soluble EPHB4 variant 1;soluble EPHB4 variant 2;soluble EPHB4 variant 3;TYRO11;Tyro5;TYRO6;tyrosine protein kinase receptor EPH 2;tyrosine protein kinase receptor EPH 3;tyrosine protein kinase receptor EPH2;tyrosine protein kinase receptor EPH3;tyrosine protein kinase receptor HTK;tyrosine protein kinase TYRO11;tyrosine protein kinase TYRO5;tyrosine protein kinase TYRO6;Tyrosine-protein kinase receptor EPH-2.